MFT
DXCM icon

Moisand Fitzgerald Tamayo’s DexCom DXCM Stock Holding History

Moisand Fitzgerald Tamayo’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-44
Closed -$4.99K – 629
2024
Q2 		$4.99K Hold
44
– – ﹤0.01% 388
2024
Q1 		$6.1K Hold
44
– – ﹤0.01% 370
2023
Q4 		$5.46K Hold
44
– – ﹤0.01% 415
2023
Q3 		$4.11K Hold
44
– – ﹤0.01% 455
2023
Q2 		$5.66K Hold
44
– – ﹤0.01% 399
2023
Q1 		$5.11K Hold
44
– – ﹤0.01% 418
2022
Q4 		$4.98K Buy
+44
New +$4.83K ﹤0.01% 416

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Moisand Fitzgerald Tamayo's DXCM Position: Q3 2024 in Review

Moisand Fitzgerald Tamayo sold out of DexCom (DXCM) in Q3 2024, closing a stake of 44 shares — an estimated $4.99K sold.

Moisand Fitzgerald Tamayo first reported a position in DXCM in Q4 2022 and held it in 7 quarters. The position peaked at $6.1K in Q1 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Moisand Fitzgerald Tamayo reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Moisand Fitzgerald Tamayo sold 44 DexCom shares in Q3 2024, an estimated $4.99K.
  • Moisand Fitzgerald Tamayo first reported a position in DexCom in Q4 2022 and held it in 7 quarters.
  • Moisand Fitzgerald Tamayo's DexCom position peaked at $6.1K in Q1 2024.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q3 2024, filed 9 Oct 2024.